Journal article
Cutaneous T-cell Lymphoma and Concomitant Atopic Dermatitis Responding to Dupilumab
Cutis (New York, N.Y.), v 106(3), pp 131-132
01 Sep 2020
PMID: 33104116
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Cutaneous T-cell lymphoma (CTCL) represents a diagnostic challenge because of its large symptomatic overlap with other common skin conditions such as atopic dermatitis (AD) and psoriasis. Dupilumab has offered promising results in AD treatment; however, concerns exist that its use may exacerbate undiagnosed CTCL. We present a patient with CTCL and concomitant AD who experienced improvement in both CTCL blood involvement and AD following the addition of dupilumab therapy.
Metrics
Details
- Title
- Cutaneous T-cell Lymphoma and Concomitant Atopic Dermatitis Responding to Dupilumab
- Creators
- Nicholas K. Mollanazar - Temple UniversityKevin T. Savage - Drexel UniversityBobak T. Pousti - Temple UniversityNeha Jariwala - University of PennsylvaniaChristina Del Guzzo - University of PennsylvaniaPaul Haun - University of PennsylvaniaCarmela C. Vittorio - University of PennsylvaniaAlain H. Rook - University of PennsylvaniaEllen J. Kim - University of PennsylvaniaAlan T Murray
- Publication Details
- Cutis (New York, N.Y.), v 106(3), pp 131-132
- Publisher
- Quadrant Healthcom Inc
- Number of pages
- 2
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:000641139900011
- Scopus ID
- 2-s2.0-85094932418
- Other Identifier
- 991019357768804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Dermatology